GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Induction Healthcare Group PLC (LSE:INHC) » Definitions » Beta

Induction Healthcare Group (LSE:INHC) Beta : -0.98 (As of Jun. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Induction Healthcare Group Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-25), Induction Healthcare Group's Beta is -0.98.


Induction Healthcare Group Beta Historical Data

The historical data trend for Induction Healthcare Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Induction Healthcare Group Beta Chart

Induction Healthcare Group Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
Beta
- - - - -

Induction Healthcare Group Semi-Annual Data
Sep18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.29

Competitive Comparison of Induction Healthcare Group's Beta

For the Health Information Services subindustry, Induction Healthcare Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Induction Healthcare Group's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Induction Healthcare Group's Beta distribution charts can be found below:

* The bar in red indicates where Induction Healthcare Group's Beta falls into.



Induction Healthcare Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Induction Healthcare Group  (LSE:INHC) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Induction Healthcare Group Beta Related Terms

Thank you for viewing the detailed overview of Induction Healthcare Group's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Induction Healthcare Group (LSE:INHC) Business Description

Traded in Other Exchanges
N/A
Address
C/o Pinsent Masons, 30 Crown Place, Earl Street, London, GBR, EC2A 4ES
Induction Healthcare Group PLC is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals. The company's mobile application module Induction Switch is an app that provides a directory allowing Healthcare Professionals to find extension numbers, messaging, and administration portals to share and view hospital guidelines. The company's products power remote consultations, capture patient-reported data and empower patients to self-manage their care pathway. Geographically, it operates in the United Kingdom, Europe, the United States and the Rest of the world, out of which the majority of revenue is derived from the United Kingdom.

Induction Healthcare Group (LSE:INHC) Headlines

No Headlines